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International Commission on Non-Ionizing Radiation Protection (ICNIRP)Abstract—Use of non-ionizing radiation (NIR) for diagnostic pur-
poses allows non-invasive assessment of the structure and function
of the human body and is widely employed in medical care.
ICNIRP has published previous statements about the protection
of patients during medical magnetic resonance imaging (MRI),
but diagnostic methods using other forms of NIR have not been
considered. This statement reviews the range of diagnostic NIR
devices currently used in clinical settings; documents the relevant
regulations and policies covering patients and health care workers;
reviews the evidence around potential health risks to patients and
health care workers exposed to diagnostic NIR; and identifies situ-
ations of high NIR exposure from diagnostic devices in which pa-
tients or health care workers might not be adequately protected
by current regulations. Diagnostic technologies were classified by
the types of NIR that they employ. The aimwas to describe the tech-
niques in terms of general device categories which may encompass
more specific devices or techniques with similar scientific princi-
ples. Relevant legally-binding regulations for protection of patients
and workers and organizations responsible for those regulations were
summarized. Review of the epidemiological evidence concerning
health risks associatedwith exposure to diagnostic NIR highlighted
a lack of data on potential risks to the fetus exposed toMRI during
the first trimester, and on long-term health risks in workers ex-
posed to MRI. Most of the relevant epidemiological evidence that
is currently available relates toMRI or ultrasound. Exposure limits
are needed for exposures from diagnostic technologies using optical
radiation within the body. There is a lack of data regarding risk of
congenital malformations following exposure to ultrasound in utero
in the first trimester and also about the possible health effects of
interactions between ultrasound and contrast media.Health Phys. 112(3):305–321; 2017
Key words: diagnostic radiology; imaging; medical radiation; ra-
diation, non-ionizing
INTRODUCTION
DIAGNOSTIC IMAGING with non-ionizing radiation (NIR) al-
lows non-invasive assessment of the structure and function
of the human body without the risks associated with imag-
ing by ionizing radiation, and is widely employed in medical
care.With advances in technology, increasingly sophisticated
devices that exploit NIR are being introduced into clinical
practice, and it is important to ensure that their use does
not carry unwarranted risks to health.
ICNIRP has published previous statements in 2004 and
2009 about the protection of patients duringmedicalmagnetic
resonance imaging (MRI), but not other forms of diagnostic
NIR. Accordingly, ICNIRP here provides updated advice re-
garding a broad spectrum of diagnostic devices employing
NIR, focusing on those that are currently used clinically.
The aims of this statement are to:
• Review the range of diagnostic devices employing NIR
that are currently used in clinical settings;
• Document the regulations and policies governing the
use of such devices for protection of patients and
health care workers;
• Describe potential risks to the health of patients
(representing volunteers and comforters also) and health
care workers (representing carers also) as a consequence
of diagnostic use of NIR; and
• Identify situations of potentially high NIR exposure to
patients or health care workers from diagnostic devices,
in which protection may not be adequate.
In regard to the last of these objectives, it is recognized
that limits on exposure often incorporate reduction factors
to allow for uncertainties in available scientific evidence,
and that the magnitude of any such adjustment will depend
on value judgements that are not simply a matter of science.
Furthermore, diagnostic procedures can confer substantial305
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306 Health Physics March 2017, Volume 112, Number 3benefits to health, such that, depending on the probability
and severity of harm, a risk of adverse effects in patients
may in some circumstances be acceptable. However, bene-
fits must outweigh the risks in order to be ethical.
For these reasons, the statement does not form any judge-
ment as to whether or not current regulatory limits are appro-
priate. Rather, it focuses onwhether there is evidence that they
fail to protect against demonstrable hazards and, if so, what
risks could be expected. In addition, it identifies gaps in cur-
rently available evidence that might mask important, unrecog-
nized risks, and that should be a priority for future research.
Consideration is limited to uses of NIR for diagnostic
procedures in patients and does not extend to its application
in diagnostic procedures conducted away from the patient
(e.g., on tissue specimens in the laboratory), nor for use
of NIR for therapeutic or cosmetic (the topic of a future
ICNIRP Statement) purposes. NIR is taken to include static
magnetic fields; time-varying electric, magnetic, and elec-
tromagnetic fields (EMF) with frequencies up to 300 GHz
(wavelengths down to 1 mm in vacuum); optical radiation
with wavelengths from 1 nm to 1 mm; and ultrasound with
frequencies of 1 MHz to 40MHz. Acoustic waves in the au-
dible spectrum are considered only where they result from
the use of NIR as defined above. Health effects which arise
from the use of devices that employ NIR, but which are not
a consequence of the NIR (e.g., claustrophobia from MRI
scanners), are not addressed.
Even with these restrictions, the relevant scientific lit-
erature is large, and it was not judged practical or efficient
to carry out a comprehensive systematic review of all perti-
nent primary research. Instead, the statement refers where
possible to systematic reviews already published by ICNIRP
or by other respected authorities (Stam and Bijwaard 2011;
de Waard-Schalkx et al. 2015) with supplementary system-
atic searches of the literature to address any important gaps
in their coverage (further details are given later).T
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8DIAGNOSTIC TECHNOLOGIES BASED ON NIR
Diagnostic technologies have been classified by the
NIR fields employed.
Electromagnetic fields
EMF with frequencies of 0 to 300 GHz are used in a
range of diagnostic devices either directly on the patient to
gather diagnostic information, or as a means of storing or
transmitting data from monitoring of patients. The benefits
of some of these devices are clear and they are used exten-
sively (e.g., MRI) whereas the clinical value of others re-
mains to be established (Table 1a).
Magnetic resonance imaging (MRI). MRI is a very
widely employed method of clinical investigation which
uses a static magnetic field, generally in the range 0.5 towww.health-physics.com
307Statement on diagnostic devices using non-ionizing radiation c ICNIRP7 Tesla (T) in combination with time-varying non-periodic
EMF (approximately in the range 100–1,000 Hz) and radio
frequency EMF (in the range 20–300 MHz). MRI can gen-
erate images providing contrast to a wide range of different
aspects of organ structure or function.With technological ad-
vances, including increases in the strengths of static magnetic
fields up to and beyond 7T, sub-millimetre resolution can now
be achieved.
Transcranial magnetic stimulation (TMS).Apart from
its wide therapeutic use, electrical stimulation of brain cor-
tex by magnetic induction is applied diagnostically to in-
vestigate brain activity. In addition, magnetic stimulation
can be used to study peripheral nerve function. Typically,
a time-varying magnetic field is applied in pulses lasting
several hundred microseconds. The equivalent frequency
based on pulse width and repetition rate can be in the lower
kHz range.
RF identification (RFID).RFID employs EM fields to
remotely identify patients, and depending on the character-
istic of the device, data such as temperature or blood glu-
cose levels can be acquired and exchanged at distances up
to a hundred meters (ICNIRP 2008). More recently, RFID
has been further developed as an “implantable” technology.
The frequencies employed in RFID range from hundreds of
kHz up to 6 GHz.
Wireless signal transfer. As well as monitoring of tem-
perature, wireless signal transfer applications include heart rate
monitoring, and exchange of this information between patient
and carer. Wireless signal transfer uses miniaturized measure-
ment devices (e.g., temperature sensors) equipped with an
RF transmitter to acquire and transmit data. The operational
frequency is fixed from 400 MHz to 10 GHz.
Radar for vital functions. Radar using pulsed and
ultra-wide band RF and MW signals is being evaluated as
a tool for non-invasive monitoring of vital functions. Two
of the diagnostic applications most advanced in develop-
ment are monitoring of breathing for early detection of
pneumothorax and monitoring for tremors. The frequencies
employed range from nearly 10 GHz up to 24 GHz.
Radar imaging. Radar imaging or MW tomography is
used mainly in the diagnosis of breast and skin cancers with
some trials on stroke detection emerging (De Santis et al.
2012). The technique exploits the difference between di-
electric properties of cancer and healthy tissue, to image
and localize tumors even in 3D. The method employs an an-
tenna array that transmits and receives. The frequency range
spans 1 GHz to 15 GHz.
Electromagnetic (EM) movement tracking. EMmove-
ment tracking is used for diagnostic purposes, for example
in analysing jaw movements during mastication. Anwww.health-phyantenna inserted at a relevant site in the patient transmits in-
formation about position.
Volumetric EMF phase-shift spectroscopy (VEPS).
VEPS is being developed to detect and measure intracranial
hematoma and oedema. The technology uses frequencies
from a few MHz up to hundreds of MHz and can detect
pathological changes in tissues, such as increased amount
of fluid, through external non-contact, multi-frequency EM
measurements. VEPS is relatively inexpensive and therefore
could be amenable for use in economically disadvantaged
parts of the world.
Microwave-induced thermo-acoustic echography.
The main application of microwave-induced thermo-acoustic
echography is breast cancer imaging. It uses a combination
of microwaves to heat tumors and acoustic waves to sense
microwave absorption. A tumor causes higher dielectric
losses of microwaves than healthy tissues, and therefore
can be selectively heated, optimally at around 800 MHz.
The expansion of the tumor because of the heat leads to a
modification in acoustic waves when emitted towards, and
reflected from, the tissue.Optical radiation
Diagnostic applications of optical radiation employ
wavelengths ranging from short wavelength ultraviolet radi-
ation through the visible spectrum to near infrared radiation
(Table 1b).
Near-infrared radiation applications. Near-infrared
radiation (near IRR) is used as a light source for in vivo in-
ternal imaging of the upper gastrointestinal tract. The radiation
is delivered through an optical fibre attached to swallowed
graded-index lens optics which illuminate the mucosa and
record the scatter of near IRR.
Another major clinical application of near IRR is op-
tical coherence tomography. A short coherence super-
luminescent light diode (SLD) is used as the source. The pri-
mary beam is split into a reference path, which is reflected
by a mirror, and a measurement path which is backscattered
by the tissues. High lateral resolution of the target tissue re-
quires it to be as close to a point source as possible, and
therefore involving high irradiance. The technology is used
as a standard diagnostic procedure in ophthalmology and
also in dermatology.
Near-infrared radiation-visible radiation (VIR) ap-
plications. Diffuse optical tomography uses near IRR and
long wavelength visible radiation, typically from an array
of diode lasers, as a primarybeam and the backscattered ra-
diation is detected for different wavelengths. The scattering
and absorption topography is calculated to create a detailed
three-dimensional image of the tissue.sics.com
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310 Health Physics March 2017, Volume 112, Number 3Near-infrared spectroscopy uses a laser or light emit-
ting diode (LED) as the source and detects backscattered
light, which is spectrally resolved to calculate cerebral and
tissue oxygenation and estimate lipid content. Near-infrared
diffuse correlation spectroscopy can be used to measure
blood flow in brain, muscle and superficial tumors with
a penetration depth of several centimeters. This technique
quantifies the motion of red blood cells by measuring fluc-
tuations in their scattering of near-infrared photons.
Intraoperative fluorescence imaging is used during sur-
gical procedures, usually to distinguish tumor tissue from
normal tissue. It employs LEDs as a source of near-
infrared radiation or visible radiation, and image contrast
is due to fluorescence. Irradiance should be below threshold
for heating when in use.
Visible radiation applications. Fast non-linear spec-
tral microscopy is used in dermatology in diagnosis of
superficial skin cancers. A very short laser pulse induces
multiple photon absorption with very high resolution, and
secondary fluorescence is then detected. This requires a
pulse time in the order of a picosecond, and with current de-
tector technology, an irradiance that exceeds the ICNIRP
exposure limit (ICNIRP 2013a).
Laser speckle imaging records fluctuations in random
interference patterns of coherent light from a laser. It is used
to quantify blood flow in superficial body tissues. Irradi-
ances normally are below the ICNIRP exposure limit. In
photoacoustic tomography, a short visible radiation pulse
of high intensity is focusedwith high resolution. The energy
that is absorbed causes a rapid increase in temperature and
some of the energy is transformed into a mechanical pres-
sure wave, an ultrasound pulse that is time-resolved and re-
corded for imaging. The magnitude of the ultrasound pulse
from a defined depth depends on the optical properties of
tissues in front of the focal point.
In fluorescence angiography, a fluorescent dye, fluo-
rescein, is injected into a peripheral vein and the filling
of the retinal vessels is observed over time by illuminationwith
an excitation light and concurrent recording of fluorescence.
White light from an incandescent source, a halogen
source or an LED lamp is used in ophthalmic surgical mi-
croscopes to induce light scattering and enable the struc-
tures of the patient’s anterior segment to be visualized.
The illumination, particularly with short wavelength visible
radiation, exceeds the ICNIRP photochemical exposure
limit (ICNIRP 2013b) and is hazardous for the patient’s ret-
ina but the exposure is necessary for safe surgery. Thus
exposure time is minimized as far as possible, with short
wavelength visible radiation filtered out.
White light from the same sources used in ophthalmic
surgical microscopes may be used also for illumination of
the retina, the backscatter being observed by the examinerwww.health-phyor recorded by a camera (fundus photography). Again the
principle is to minimize irradiance and exposure time as
far as possible (see below).
In endomicroscopy, light of different wavelengths from
laser diodes is delivered via a fiber. The fibre tip is coupled
into a miniature graded-index lens microscope that focuses
the light on the mucosa of the upper gastrointestinal tract,
and the backscattered light is imaged with the microscope
and recorded as spectrally-resolved wavelength-dependent
absorption images.
Visible radiation-ultraviolet radiation applications.
In confocal laser scanning microscopy, the illumination is
confocal with the focal point of the microscope. Typically,
a laser emitting in the visible radiation waveband is used
for illumination. The technique is used to image the mucosa
of internal organs and for retinal and skin imaging.
Ultrasound
Ultrasound is a form of oscillating mechanical energy
with frequency higher than 20 kHz, a cut-point which is
above the audible frequency range for most people. Diag-
nostic ultrasound devices operate at between 1 MHz and
40 MHz.
Diagnostic ultrasound has advanced remarkably in the
past 50 years. It can provide exquisite visualization of inter-
nal anatomy and is used extensively in clinical practice.
Currently, pregnant women in most countries are examined
with ultrasound at least once.
Diagnostic ultrasound machines operate with different
modes. In the Amode the intensities of echoes from various
depths are resolved in one dimension. In B-mode the ultra-
sound beam is scanned in two dimensions thus providing
2D information. In C-mode, several adjacent B-scans are
stacked together to provide 3D information. In M mode,
the B-scan or the C-scan is resolved over time thus showing
motion in the tissue examined. In the Doppler mode the
scan is used to assess the velocity of blood flow or a moving
internal structure, which is determined by measuring the
Doppler shift of frequency in returning echoes. A summary
of ultrasound techniques is given in Table 1c.INTERNATIONAL AND NATIONAL
REGULATORY STRUCTURES
Several independent organizations have published guide-
lines on the avoidance of harm from exposures to NIR gen-
erated by diagnostic devices (Table 2). These guidelines
may be used by governmental bodies that issue legally-
binding regulations on exposures to NIR.
Regulation of medical devices is intended to ensure ef-
fective medical devices of good quality that are safe for the
intended purpose. The essential requirements concern the
protection of the users and the environment. In mostsics.com
Table 2. Examples of organisations issuing legally binding regulation and guidelines for human protection against hazardous
health effects of NIR.
Governmental organizations issuing legally binding regulations
ARPANSA Australian Radiation Protection and Nuclear Safety Agency
EU European Union (Parliament and Council)
FDA Food and Drug Administration (eg China, Korea, USA)
TGA Therapeutic Good Administration (Australia)
NEA National Environmental Agency (Singapore)
FSSCRHW Federal Service for Supervision of Consumer Rights and Human
Welfare (Russia)
Organizations issuing guidelines
ACGIH American Conference of Gavernmental Industrial Hygienists
ACOG American Congress of Obstetricians and Gynecologists
ACR Americal College of Radiology
AIUM American Institute of Ultrasound in Medicine
ARPANSA Australian Radiation Protection and Nuclear Safety Agency
ASUM Australasian Society for Ultrasound in Medicine
(Australia, New Zealand)
BIR British Institute of Radiology (UK)
BMUS British Medical Ultrasound Society (UK)
ECMUS European Committee of Medical Ultrasound Safety
HVBG Hauptverband der gewerblichen Berufsgenossenschaften (Germany)
ICNIRP International Commission on Non-Ionizing Radiation Protection
IEC International Electrotechnical Committee
JSOH Japan Society for Occupational Health (Japan)
MHRA Medicines and Healthcare products Regulatory Authority (UK)
NHMRC National Health and Medical Research Council (Australia)
PHE Public Health England (formerly Health Protection Agency) (UK)
RCR Royal College of Radiologists (UK)
SSK Strahlenschutzkommission (Germany)
WFUMB World Federation of Ultrasound in Medicine and Biology
311Statement on diagnostic devices using non-ionizing radiation c ICNIRPcountries that regulate medical devices, a national regu-
latory authority (NRA) sets regulatory controls in pre-
market, on the market and post-market phases of the
medical device. The safe use of medical devices in health
care settings is usually not the responsibility of the NRA.
In European Union (EU) countries, EU Directives reg-
ulating exposures from NIR devices are implemented by
transposition into national laws or regulations. Separate di-
rectives cover devices, patients and workers (Tables 3a–c;
4a–c). It is notable that in the recent EU Directive (2013/
35/EU) limiting the exposure of workers to electromagnetic
fields, exposures from MRI used in the healthcare sector
could exceed the exposure limit values, provided other condi-
tionswere satisfied. On the other hand, EUmember states are
free to apply stricter limits for workers than those in the EMF
directive and some (e.g., Poland) have already done so.
In the Russian Federation, medical devices and activ-
ities must comply with a federal sanitary regulation which
lists fixed emission limits for NIR. In addition, there are
federal regulations for workers with occupational expo-
sure limits for EMF, infrared, and ultraviolet radiation.
The occupational EMF limits are stricter than ICNIRPwww.health-phyoccupational reference levels and depend on the duration
of exposure.
In many Asian countries, a law is passed by the country’s
legislative body creating an NRA that then issues the regu-
lations. Examples of NRAs that regulate medical devices
(mainly through registration of such devices) are the Food
and Drug Administration of the Philippines, the Malaysia
Medical Device Authority, the Thai Food and Drug Admin-
istration, the China Food and Drug Administration, the
Hong Kong Medical Device Control Office, the Ministry
of Food and Drug Safety of Korea, and the VietnamDepart-
ment of Medical Equipment and Health Works. In Singapore,
the National Environment Agency regulates use of devices
while the Health Sciences Authority regulates production,
import, export, sale, and distribution of medical devices.
In the Philippines, the Food and Drug Administration regu-
lates not just the production, import, export, sale, and dis-
tribution of medical and radiation devices but also their
use, when applicable. In November 2014, the Association
of Southeast Asian Nations (ASEAN) signed the ASEAN
Medical Device Directive (AMDD), which establishes a
harmonized regulatory model for medical device regulationsics.com
Table 3a. Examples of legally binding regulations associated with diagnostic devices based on NIR for protection of patients,
static fields and time varying electromagnetic fields less than 0.3 THz.
Region Year in force Regulator Document and principle
Australia 1989, 2002 Therapeutic Goods Administration (TGA) Therapeutic Goods Act 1989 and the Therapeutic Goods
(Medical Devices) Regulations 2002.
China 2000 Food and Drug Administration (FDA), China Regulations for the supervision and administration of
medical devices.
Hong Kong 2012 Hong Kong Dept. of Health Pharmacy and poinsons ordinance, Radiation ordinance,
Telecommunications ordinance.
Taiwan 2015 Taiwan FDA Pharmaceutical affairs law-Regulations for governing the
management of medical devices, regulations for
registration of medical devices
EU 1993, 2007 European Union (EU) Council Directive 93/42/EEC concerning medical devices.
Local regulation is delegated to national notifying
authorities in each member state. Devices may be placed
on market if they do not comprimise safety and health of
patients, users and other persons. Appendix 11 specifies
requirements on radiation emission. To be replaced by
Medical device regulations.
Japan 2014 Pharmaceuticals and Medical Devices
Agency (PMDA), Ministry of Health
Labour and Welfare
Act on Securing Quality, Efficacy, and Safety of
Pharmaceuticals,
Medical Devices, Regenerative and Cellular Therapy
Products, Gene Therapy Products, and Cosmetics
Korea 2010 Food and Drug Administration (FDA),
Dept. of Health, Korea
Medical Device Act
Malaysia 2012 Medical Device Authority, Ministry
of Health
Medical Device Act
Philippines
2009 Food and Drug Administration
Philippines (FDA), Dept. of Health
Food and Drug Administration Act and the appropriate
regulation for registration of medical devices 2016.
2004 Bureau of Health Devices and Technology,
Dept. of Health
Radiation protection standards for radiofrequency radiation
in the range 3 kHz–300 GHz
2007 Bureau of Health Devices and Technology,
Dept. of Health
Amendment to implementing rules and regulations of code
of sanitation of the Philippines.
Russia 2010 Chief Medical Officer, Federal Service for
Supervision of Consumer Rights Protection
and Human Welfare (FSSPCRHW)
SanPiN 2.1.3.2630-10, Organization of medical activities
Singapore
2014 National Environment Agency Radiation Protection (Amendment) Act 2014
2016 Health Sciences Authority Health Products Act
USA
1998 Food and Drug Administration USA (FDA) Guidance for the submission of premarket notifications for
MR diagnostic devices
2003 Food and Drug Administration USA (FDA) Criteria for significant risk investigations of MRI devices
2005 Food and Drug Administration USA (FDA) Federal food, drug and cosmetic act, regulates marketing of
radiation emitting products, additional requirements for
medical devices
2008 Food and Drug Administration USA (FDA) Establishing safety and compatibility for passive implants in
the magnetic resonance (MR) environment
312 Health Physics March 2017, Volume 112, Number 3for its member states. The regulation will come into force
upon ratification.
The U.S. Food and Drug Administration implements
its federal Food, Drugs, and Cosmetics Act by issuing regu-
lations which become part of the U.S. Code of Federal Reg-
ulations. Individual states of the U.S. may have further
regulations for the use of NIR medical devices. Arizona,
which is an example of a state with regulations on the use
of NIR devices, requires the registration of non-ionizing
radiation facilities. At the same time, a non-governmentalwww.health-phyorganization, the American College of Radiology (ACR),
operates a scheme for accreditation of MRI facilities (and
offers this service internationally). Similarly, the American
Institute of Ultrasound in Medicine accredits clinical facili-
ties using ultrasound. Although accreditation is voluntary, it
is required for reimbursement by many private health insur-
ance companies.
In many countries, there is no legislation/regulation
governing the use of NIR in diagnostic devices. Instead,
practitioners refer to guidelines issued by national orsics.com
Table 3b. Examples of legally binding regulations associated with diagnostic devices based on NIR for protection of patients,
optical radiation (1 nm-1 mm).
Region Year in force Regulator Document
Australia 1989, 2002 Therapeutic Goods Administration (TGA) Therapeutic Goods Act 1989 and the Therapeutic Goods
(Medical Devices) Regulations 2002.
China 2000 Food and Drug Administration (FDA), China Regulations for the supervision and administration
of medical devices.
Hong Kong 2012 Hong Kong Dept. of Health Pharmacy and poinsons ordinance, Radiation ordinance,
Telecommunications ordinance.
Taiwan 2015 Taiwan FDA Pharmaceutical affairs law-Regulations for governing the
management of medical devices, regulations for
registration of medical devices
EU
1993
2007
European Union (EU) Council Directive 93/42/EEC concerning medical
devices. Local regulation is delegated to national
notifying authorities in each member state. Devices
may be placed on market if they do not comprimise
safety and health of patients, users and other persons,
appendix 11 specifies requirements on radiation
emission (no specific limits)
Japan 2014 Pharmaceuticals and Medical Devices Agency
(PMDA), Ministry of Health Labour
and Welfare
Act on Securing Quality, Efficacy, and Safety of
Pharmaceuticals, Medical Devices, Regenerative and
Cellular Therapy Products, Gene Therapy Products,
and Cosmetics
Korea 2010 Food and Drug Administration (FDA),
Dept. of Health, Korea
Medical Device Act
Malaysia 2012 Medical Device Authority, Ministry of Health Medical Device Act
Philippines 2009 Food and Drug Administration Philippines
(FDA), Dept. of Health
Food and Drug Administration Act and the appropriate
regulation for registration of medical devices 2016.
Russia 2010 Chief Medical Officer, Federal Service for
Supervision of Consumer Rights Protection
and Human Welfare (FSSPCRHW)
SanPiN 2.1.3.2630-10, Organization of medical activities
Singapore
2014 National Environment Agency Radiation Protection (Amendment) Act 2014
2016 Health Sciences Authority Health Products Act
USA 2005 Food and Drug Administration (U.S. FDA) Federal food, drug and cosmetic act, regulates marketing
of radiation emitting products, additional requirements
for medical devices
313Statement on diagnostic devices using non-ionizing radiation c ICNIRPinternational or professional associations. These guidelines
may or may not be followed.
Legislation/Regulation for protection of patients
Legally-binding regulations associated with diagnostic
devices based on NIR intended for protection of patients are
listed in Table 3a–c.
Legislation/Regulation for protection of health workers
Legally binding regulations associated with diagnostic
devices based on NIR intended for protection of workers
are listed in Table 4a–c.EPIDEMIOLOGICAL EVIDENCE FOR HEALTH
RISKS ASSOCIATEDWITH EXPOSURE TO
DIAGNOSTIC NIR DEVICES
Most of the relevant epidemiological evidence that is
currently available relates to MRI or ultrasound.www.health-phyMRI
Research on possible adverse effects from diagnos-
tic use of MRI was identified by a non-systematic review
of the literature for relevant epidemiological studies
and clinical reports and by hand-searching references
of key reports.
Overall, MRI has been used clinically for about three
decades with apparently few serious side effects aside from
well-documented acute injuries resulting from effects on
implanted electronic devices or acceleration of ferromag-
netic materials towards the scanner by the magnetic field,
or from RF-induced burns due to poor positioning of the pa-
tient in the scanner.
Previous reviews of the health effects of fields of MRI
equipment do not suggest long-term adverse health effects
(HPA 2008a; ICNIRP 2009a). This is particularly the case
for static fields (WHO 2006; HPA 2008b; ICNIRP 2009b),
for which there is no substantiated evidence for any health
effect that could inform the design of an epidemiologicalsics.com
Table 3c. Examples to show range of legally binding regulations associated with diagnostic devices based on NIR for
protection of patients, ultrasound.
Region Year in force Regulator Document
Australia 1989, 2002 Therapeutic Goods Administration (TGA),
Dept. of health
Therapeutic Goods Act 1989 and the Therapeutic
Goods (Medical Devices) Regulations 2002.
China 2000 China Food and Drug Administration
(CFDA), China
Regulations for the supervision and administration
of medical devices.
Hong Kong 2012 Hong Kong Dept. of Health Pharmacy and poisons ordinance
Taiwan 2015 Taiwan FDA Pharmaceutical affairs law-Regulations for governing the
management of medical devices, regulations for
registration of medical devices
EU 1993, 2007 European Union (EU) Council Directive 93/42/EEC concerning medical devices.
Japan 2014 Pharmaceuticals and Medical Devices Agency
(PMDA), Ministry of Health Labour
and Welfare
Act on Securing Quality, Efficacy, and Safety of
Pharmaceuticals, Medical Devices, Regenerative and
Cellular Therapy Products, Gene Therapy Products,
and Cosmetics
Korea 2010 Food and Drug Administration (FDA),
Dept. of Health, Korea
Medical Device Act
Malaysia 2012 Medical Device Authority, Ministry of Health Medical Device Act
Philippines 2009 Food and Drug Administration Philippines
(FDA), Dept. of Health
Food and Drug Administration Act and the appropriate
regulation for registration of medical devices 2016.
Russia 2010 Chief Medical Officer, Federal Service for
Supervision of Consumer Rights Protection
and Human Welfare (FSSPCRHW)
SanPiN 2.1.3.2630-10, Organization of medical activities
Singapore
2014 National Environment Agency Radiation Protection (Amendment) Act 2014
2016 Health Sciences Authority Health Products Act
USA 2005 Food and drug Administration (U.S. FDA) Federal Food, Drug and Cosmetic Act, section 513,
regulates marketing of radiation emitting products,
additional requirements for medical devices
314 Health Physics March 2017, Volume 112, Number 3study. However, the effect of RF power deposition in tissues
should be investigated.
Patients: Acute perceptual and cognitive effects.Acute
perceptual and cognitive effects are well recognized effects
that have been reported by subjects undergoing diagnostic
MRI. They occur particularly when high static magnetic fields
are employed (Rauschenberg et al. 2014), but symptoms
have sometimes been reported in relation to field strengths
as low as 1.5 T (Heilmaier et al. 2011). The largest study
available was a multicentre trial that used 7 T and 9.4 T
MRI systems and collected data through 3,457 completed
questionnaires (Rauschenberg et al. 2014). The study aimed
to separate sensory side effects during movement on the pa-
tient table from those experienced while lying still at the
isocenter. Most participants (82%) rated the examination
at least as tolerable; 8% felt discomfort; and only 1% of
the image acquisitions had to be terminated prematurely.
No adverse events occurred in any examination. Only 1%
of the subjects were unwilling to undergo further ultra-
high field MRI examinations. Long duration of examina-
tion was the most frequent cause of discomfort, followed
by acoustic noise and lying still. All magnetic-field-related
sensations were more pronounced when moving the patient
table compared to resting at the isocenter position (19%/2%www.health-phyof the subjects felt unpleasant vertigo during the moving/
stationary state). Vertigo was the most frequently reported
sensory side effect overall, and was more pronounced at
9.4 T than at 7 T, although its prevalence varied substan-
tially between the different trial sites. Several mechanisms
have been proposed to explain this vertigo including differ-
ences in magnetic susceptibility between the vestibular or-
gans and surrounding fluid, induced currents acting on
hair cells (Glover et al. 2007) or the Lorentz force inside
the lateral semi-circular canal (Roberts et al. 2011).
Patients: Developmental effects of prenatal MRI. A
large prospective observational study examining the effects
of prenatal exposure to 1.5-T MRI on developmental out-
come (Bouyssi-Kobar et al. 2015), as assessed by a norm-
referenced, psychometrically sound functional assessment
scale, found no association with adverse functional out-
comes or hearing impairment.
Medium- to long-term ill-effects of undergoing diag-
nostic MRI are believed to be few, though there is a dearth
of epidemiological studies to evaluate this. This may reflect
the difficulty of designing patient-studies that are not sub-
stantially confounded. Firstly, both the medical indication
for the scan and the range of associated investigations and
treatments may have their own health consequences.sics.com
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317Statement on diagnostic devices using non-ionizing radiation c ICNIRPSecondly, MRI is often associated with the administration
of contrast agents which themselves can have clear short-
and medium-term effects (e.g. accumulation of gadolin-
ium from contrast agents in the body). Using a control
group who have had a CT scan, for example, is not feasi-
ble since CT carries its own, established health risks. A
future opportunity to obtain unbiased data about possible
health effects of diagnostic MRI arises from its use in
large population-based longitudinal studies. For example,
the UK Biobank project is planning to phenotype 100,000
apparently healthy subjects in the next few years using
MRI, although their exposure will be limited. There are
also other groups (such as workers and consumers in-
volved in neuro-marketing) who volunteer for MR scans
and receive regular, high exposure over several years.
While these voluntary exposures vary considerably and
may be confounded by other exposures such as to ioniz-
ing radiation, such groups may be a useful resource for
epidemiological research in the future. While molecular
changes have been demonstrated following in vitro exper-
imental exposures to magnetic fields (with and without
contrast agents) (Fiechter et al. 2013; Lancellotti et al.
2015; Vijayalaxmi et al. 2015), such findings have not
been reflected in the limited evidence that is available
on health outcomes.
Health workers: Acute perceptual and cognitive effects
It has long been known that people working in the vi-
cinity of MRI scanners can experience transient vertigo
(as well as a metallic taste in their mouths). These effects oc-
cur not only with movement in the field, but also when peo-
ple are stationary, and they become pronounced when staff
work inside or close to the end of the bore (where the field
can be particularly high for shielded magnets). Underlying
mechanisms that have been proposed include hydrodynamic
effects in the vestibular system (Schenck 2005; Glover et al.
2007), and a direct magnetic susceptibility effect on the sen-
sory hair cells (Glover et al. 2007), but currently the ac-
cepted mechanism is a Lorentz force on the dark current
within the vestibular system (Roberts et al. 2011).
A study among 361 healthcare and research staff work-
ing with MRI scanners in the Netherlands (Schaap et al.
2014) assessed the incidence and association of transient
perceptual symptoms with static magnetic field exposure
based on diaries reporting work activities and symptoms
during work shifts inside and/or outside an MRI facility.
Participants included both MRI staff and radiographers
who never worked with MRI. Symptoms (mainly vertigo
and metallic taste) were reported during 16–39% of the
MRI work shifts, and there were significant positive associ-
ations with increasing scanner strength, ranging from 2-fold
increases at 1.5 T to 4‐fold increases at 7.0 T. A meta-
analysis of 5 studies published during 1992–2007 foundwww.health-phythe only neuropsychological effect relating to static mag-
netic field exposure to be visual impairment. Further re-
search into this possibility is needed.
Health workers: Pregnancy outcomes
One study compared self-reported pregnancy outcomes
of female MRI workers from the 1990s (Kanal et al. 1993)
(when fields were lower than today but extended further to
non-MRI workers) adjusted for age, smoking, and alcohol
use. No increase in risk of spontaneous abortions, delayed
conception, early delivery, low birth weight, or male sex
of offspring was seen compared to when they were em-
ployed elsewhere before working with MRI.Optical radiation
A current literature search did not reveal any studies in-
dicating adverse effects associated with the use of optical ra-
diation in diagnostic procedures. Surveillance programs for
workers using laser applications had not revealed any unex-
pected health hazards by the early 1990s, and since then
have been abandoned in most countries.Ultrasound
Research on possible adverse effects from diagnostic
use of ultrasound was identified from a previous systematic
review (HPA 2010), and through a systematic search of the
Embase and Ovid Medline databases, looking for relevant
epidemiological studies and clinical case reports. Informa-
tion was found concerning potential acute effects, longer
term obstetric and developmental outcomes following use
of ultrasound during pregnancy, and risk of childhood can-
cer after prenatal exposure to ultrasound.
Acute effects
Possible acute effects that have been investigated in-
clude stimulation of foetal movements during the later
stages of pregnancy (Fatemi et al. 2001); altered electroen-
cephalographic (EEG) activity in neonates during and after
ultrasound examination (Kohorn et al. 1967); erythrocyte
fragility in women exposed to continuous ultrasound
monitoring during labor (Bause et al. 1983); and structural
changes in the brain (assessed by MRI) following
insonation through the temporal bone (Schlachetzki et al.
2002). Adverse outcomes reported to follow ultrasound im-
aging of the liver (Piscaglia et al. 2006) and heart (van der
Wouw et al. 2000) may have been a toxic effect of contrast
agents (such as microbubbles with high echogenicity used
to enhance the sonogram), and cannot be attributed to ultra-
sound exposure per se with certainty. They could also reflect
an interaction between ultrasound and contrast agents.
Study findings to date do not point clearly to any acutesics.com
318 Health Physics March 2017, Volume 112, Number 3adverse effects of human exposure to diagnostic ultrasound,
but further research on possible interactions with contrast
agents would be useful.
Pregnancy and birth outcomes
B-scans are used for dating conception, identifying
multiple pregnancies, fetal abnormalities, and placental lo-
cation. Later in pregnancy, Doppler studies, usually
employing continuous wave sources, may be used to study
blood flow in the umbilical artery as a guide to fetal well-
being, while low intensity Doppler ultrasound is often used
to monitor fetal heart rate (cardiotocography). The pro-
gressive adoption of these techniques over the last 50 years
has been so extensive that in many countries, almost all
pregnancies now entail some exposure to ultrasound. Thus
most research on humans has compared higher with lower
exposures rather than exposure with no exposure.
A substantial number of observational studies have
assessed outcomes of pregnancy in relation to exposure to
diagnostic ultrasound, but in some investigations, associa-
tions may have been confounded by the clinical indications
for ultrasound examination. Such confounding could occur
if diagnostic ultrasound were used more frequently in pa-
tients already at higher risk of adverse outcomes. However,
results of more than 25 randomized controlled trials of ultra-
sound scans at different stages of pregnancy, or of Doppler
studies of the umbilical artery, do not suggest any adverse
effects of ultrasound examination on miscarriage rate, ges-
tational age at delivery, or perinatal mortality (Bucher and
Schmidt 1993; McKenna et al. 2003; Skråstad et al. 2013).
Similarly, the balance of evidence does not indicate any ad-
verse effect of prenatal ultrasound on anthropometric mea-
sures at birth or neonatal morbidity (Alfirevic and Neilson
1995; McKenna et al. 2003; Skråstad et al. 2013), though
evidence about specific congenital malformations is limited
(Hellman et al. 1970; Mukubo 1986; Tikkanen and Heinonen
1992). In theory, congenital malformations might be an ad-
verse outcome, especially from high intensity exposures in
the first trimester, since they may be induced by heating.
However, it is unlikely that increases in temperature from
diagnostic ultrasound as currently used would be sufficient
to cause congenital abnormalities.
Developmental outcomes
Research using various designs, including case-control
and cohort studies and randomized controlled trials, has ex-
plored the relationship of diagnostic ultrasound in preg-
nancy to a wide range of developmental outcomes in
childhood—namely, growth, vision, hearing and speech,
reading and intellectual performance, handedness and men-
tal health (Salvesen et al. 1992a and b, 1993a and b; Kieler
et al. 1997, 1998a and b, 2001, 2002, 2005). Among these,
the only possible association to emerge has been with non-
right-handedness (Salvesen et al. 1993b) (a possible markerwww.health-phyfor adverse impacts on neurological development). How-
ever, the findings on this have not been entirely consistent,
and it cannot be regarded as an established effect.
Childhood cancer
Case-control studies of the risk of childhood cancer
collectively suggest that prenatal exposure to ultrasound
does not increase the risk of any of the most common types
of childhood cancer (Shu et al. 1994, 2002; Sorahan et al.
1995). Although the results of some studies may have been
biased by selective participation (e.g. controls being
unrepresentatively affluent or better educated) or by
mothers’ inaccurate recall of exposure, it seems unlikely
that this would have obscured important associations.
Moreover, studies that ascertained exposures only from
medical records (Naumburg et al., 2000; Stålberg et al.
2008) did not suggest higher risks.
Risks to patients
The balance of evidence now available does not point
to any serious adverse effects in patients from exposure to
diagnostic ultrasound as used in normal clinical practice,
in the absence of ultrasound contrast agents.
Risks to workers
No studies were found that directly examined potential
health risks in health care workers using diagnostic ultra-
sound. However, given the apparent absence of harm in pa-
tients, and the low exposure of operators (perhaps most
likely to occur if they informally test the ultrasound probe
on their arm before applying it to the patient), no risk would
be expected from current exposures.
Uncertainties
Among the uncertainties in the current evidence base,
highest priorities for further research are the risks of con-
genital malformations following exposure to ultrasound in
utero (particularly in the first trimester), and the potential
for adverse effects from interactions between ultrasound
and contrast media, on which relatively little information
is available.POTENTIAL HEALTH RISKS NOT COVERED BY
LEGISLATION/REGULATION AND IMPORTANT
AREAS OF UNCERTAINTY
Static magnetic field and radiofrequency EMF
Apart from MRI, specific guidelines or regulations to
limit exposure and/or quantify dose in patients or health
workers are few. For example, while there are occupational
studies (Karlström et al. 2006) and safety guidelines (Rossi
et al. 2009) concerning TMS, these mostly concern thera-
peutic applications. Evaluation of health effects or safety
risks for many NIR diagnostic methods is therefore difficult
and deserves further research.sics.com
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with several adverse effects in patients, including a potential
for uncomfortable exposure to acoustic noise, heating, and
sensory disturbances (in particular vertigo). However, all
of these effects are reversible and can be prevented or ame-
liorated. There is insufficient evidence on which to draw
firm conclusions about long-term health effects, although
there is little theoretical reason to expect any permanent
damage if scanners are operated in linewith existing regula-
tions. A priority for further research is to investigate any po-
tential harmful effects from exposure to the fetus during
pregnancy, particularly during the first trimester.
Potential effects on healthworkers. In normal clinical
practice, staff working with MRI scanners may experience
transient vertigo and related sensory disturbanceswhichmight
carry a risk of personal injury. Again, there is insufficient
evidence from which to draw solid conclusions about long-
term risks to health, although theoretical considerations
suggest that a hazard is unlikely. More information on any
long-term effects in well-defined MRI worker cohorts
would be useful.
Optical radiation
No reports were found of adverse short- or long-term
health effects, either in patients or in health care workers,
from diagnostic technologies using optical radiation that
complied with current guidelines.
Potential risks to the patient. Regulations for avoid-
ance of skin and eye damage from diagnostic exposure are
based on tissue-specific estimates of thresholds across the
optical spectrum for short-term onset (within a week), and
cover exposure times from femtoseconds to hrs. Accidental
ocular exposure is potentially hazardous and data on thresh-
olds for effects from exposures to repetitive short pulses are
limited. However, the reduction factor that is applied in cur-
rent regulations and guidelines for safe exposure should be
sufficiently conservative to protect against injury.
As there is little or no systematic information on
threshold doses for harm from exposures to optical radiation
within the body, no specific regulations have been devel-
oped. However, exposure limits for such exposures would
be useful.
Potential risks in health workers. Regulations place
controls on the geometry of spaces where diagnostic tech-
nologies using optical radiation are used. Moreover, special
warning lights must be mounted outside such spaces, where
exposures could exceed regulatory limits. Both of these re-
quirements are intended to avoid any exposure without use
of protective equipment.
Optical radiation can efficiently be blocked by safety
goggles. Appropriate use of safety goggles in a space where
diagnostic technologies using optical radiation are used iswww.health-phyrequired by regulations and eliminates any risk for health
workers being exposed to harmful doses.
Ultrasound
The balance of evidence now available does not point
to any harmful effects, either in patients or health careworkers,
from exposure to diagnostic ultrasound as used in normal
clinical practice, in the absence of contrast agents.
It would, however, be useful to carry out further re-
search on the risks of congenital malformations following
exposure to ultrasound in utero (particularly in the first tri-
mester), and the potential for adverse effects from interac-
tions between ultrasound and contrast media.
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